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Abstract
Background: The prevalence and risk factors of potentially inappropriate medication use among
the elderly patients have been studied in various countries, but because of the difficulty of obtaining
data on patient characteristics and medications they have not been studied in Japan.
Methods: We conducted a retrospective cross-sectional study in 17 Japanese long-term care
(LTC) facilities by collecting data from the comprehensive MDS assessment forms for 1669 patients
aged 65 years and over who were assessed between January and July of 2002. Potentially
inappropriate medications were identified on the basis of the 2003 Beers criteria.
Results: The patients in the sample were similar in terms of demographic characteristics to those
in the national survey. Our study revealed that 356 (21.1%) of the patients were treated with
potentially inappropriate medication independent of disease or condition. The most commonly
inappropriately prescribed medication was ticlopidine, which had been prescribed for 107 patients
(6.3%). There were 300 (18.0%) patients treated with at least 1 inappropriate medication
dependent on the disease or condition. The highest prevalence of inappropriate medication use
dependent on the disease or condition was found in patients with chronic constipation. Multiple
logistic regression analysis revealed psychotropic drug use (OR = 1.511), medication cost of per
day (OR = 1.173), number of medications (OR = 1.140), and age (OR = 0.981) as factors related
to inappropriate medication use independent of disease or condition. Neither patient
characteristics nor facility characteristics emerged as predictors of inappropriate prescription.
Conclusion: The prevalence and predictors of inappropriate medication use in Japanese LTC
facilities were similar to those in other countries.
Background
Inappropriate medication prescription for elderly is a
major concern because it increases the risk of adverse
events and health care costs [1]. Criteria defining inappro-
priate medication for the elderly have been developed in
order to decrease its occurrence [2-5].
Beers criteria [6-8] have been most widely used to estimate
prescription of potentially inappropriate medication for
nursing home residents, hospital inpatients, and the com-
munity-dwelling elderly in the United States, Canada and
European countries [9-47]. However, an extensive litera-
ture search did not retrieve any reports on its prevalence
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in Japanese long-term care (LTC) facilities which are of
three types: long-term care hospitals (LTCHs), health
facilities for the elderly (HFEs), and nursing homes
(NHs). The care-mix among LTCHs, HFEs and NHs over-
lap, but LTCHs tend to care for the severer medical cases,
HFEs for light care cases requiring rehabilitation, and NHs
for the stable heavy care cases. There is 24 hour physician
and nurse coverage in LTCHs, usually 24 hour nurse cov-
erage but only weekday day-time physician coverage in
HFEs, and only weekday work hour nurse coverage in
NHs [48,49]. Regarding medications, in two of the three
types of LTC facilities in Japan, LTCHs and HFEs, the cost
of medication is included in the per-diem fee, so the med-
ications prescribed are not listed on the claims forms. In
the third, NHs, medication is prescribed by independent
physicians and dispensed by free-standing pharmacies.
Although it is theoretically possible to obtain data from
the claims forms filed by the pharmacies, it has so far not
been possible to link the data with the patient assessment
data from the NHs. In all three types of facilities, data on
diagnosis and functional status at the patient level are very
difficult to obtain because there are neither uniform
assessment forms nor any formal mechanisms for data
collection. As a result, quality monitoring remains
focused on only structural aspects, such as staffing, and
there is no formal process of pharmacy reviews.
In this study, we focused on the LTC facilities that rou-
tinely use the Minimum Data Set (MDS) [50,51] as an
assessment instrument for drawing care plans and for
monitoring quality. The MDS includes individual patient
level information, not only on health or functional status,
but also on prescriptions, and has been demonstrated to
be highly reliable in the Japanese population [48]. How-
ever, the number of LTC facilities that use the MDS are
limited, since the form is not mandated in Japan. There-
fore, the database we assembled was the only one availa-
ble for evaluating the prevalence of prescription of
potentially inappropriate medication for the elderly in
Japanese LTC facilities and analyzing its predictors.
Methods
Sample
This study was conducted in 17 LTC facilities in Japan
located throughout the country. We collected the MDS
assessment data on 1883 patients aged 65 years and over
who were assessed between January and July 2002.
Because data on medication prescription for 214 patients
were missing, they were excluded. As a result, the database
was constructed from the data for the 1669 patients whose
data were complete (477 in 8 NHs, 374 in 5 HFEs, and
818 in 4 LTCHs). There were no differences in demo-
graphic characteristics (gender, age) between the 1669
subjects of this study and the 214 who were excluded.
Table 1: Inappropriate medication criteria excluded from the analysis
Excluded from the criteria independent of disease or condition:
Because the drugs were unavailable in Japan
Propoxyphene Hyoscyamine
Trimethobenzamide Tripelennamine
Carisoprodol Dexchlorpheniramine
Medaxalone Cyclandelate
Cyclobenzaprine Meperidine
Chlordiazepoxide-amitriptyline Ketorolac
Perphenazine-amitriptyline Daily fluoxetine
Doxepine Orphenadrine
Meprobamate Guanethidine
Oxazepam Guanadrel
Temazepam Nitrofurantoin
Clidinium-chlordiazepoxide Mesoridazine
Halazepam Mineral oil
Chlorazepate Amphetamines (excluding methylphenidate hydrochloride and 
anorexics)
Because long-term use could not be tracked
Long-term use of full-dosage, longer-half life, non-COX-selective NSAIDs
Long-term use of stimulant laxatives
Excluded from the criteria dependent on disease or condition:
Because the drug was unavailable in Japan
Seizure disorder (Bupropion was unavailable.)
Because the patients with these disease or conditions could not be identified
Gastric or duodenal ulcers SIADH/hyponatremia
Bladder outflow obstructionBMC Geriatrics 2006, 6:1 http://www.biomedcentral.com/1471-2318/6/1
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Data collection
The MDS instrument provides individual level data on the
following: background information, such as age, gender,
payment source; patient status such as cognitive patterns,
physical functioning; and the care provided. Trained staff
in each facility filled in the MDS form for each patient by
using information obtained through interviews, observa-
tions and chart reviews. The MDS also includes detailed
information on the medication prescribed during the last
7 days, including the names and doses of the drugs pre-
scribed, their route of administration, and total dosage. A
database that included scheduled medication, non-sched-
uled medication, and PRN medication used at the assess-
ment reference date was constructed. It also included oral
medication, external preparations, and injections, but
over-the-counter medications were excluded because the
data were incomplete.
We also used the MDS ADL Self-Performance Hierarchy in
the MDS assessment database, to obtain a composite
score for ADL functional status [52]. The scale ranges from
0 (independent) to 6 (total dependence). In this study, a
score of 2 (limited impairment) or more were classified as
having an ADL disability. Cognitive impairment was
assessed by the Cognitive Performance Scale (CPS) [53],
which ranges from 0 (intact) to 6 (very severe impair-
ment), and a score of 2 (mild impairment) or more were
classified as cognitively impaired. Depression was scored
by the Depression Rating Scale (DRS) [54], which ranges
from 0 to 14, and a score of 3 or more were classified as
depressed as defined by the developers of the scale.
Measurements
We used the 3rd version of the Beers criteria [8] to identify
prescription of potentially inappropriate medication,
which are more useful for screening prescriptions that
include potentially inappropriate medication than others.
We applied the 2003 Beers criteria in this study even
though the data were collected in 2002, before the publi-
cation of the 2003 version, because we concluded that the
differences between the versions would have little impact
in Japan since very few physicians are familiar with the
Beers criteria and the later version was more comprehen-
sive. We thought that the 2003 version served our purpose
of estimating the current prevalence of inappropriate
medication use in Japanese LTC facilities based on the cur-
rent guidelines.
The 2003 Beers criteria consist of 2 lists. One is a list of 49
individual medications or medication classes that are
inappropriate for patients 65 years or older regardless of
their disease or condition. The other is a list of 56 medica-
tions or medication classes in 19 diseases or conditions
for which they should be avoided.
In this study, we focused on the 30 medications or medi-
cation classes and 15 diseases or conditions. All the med-
ications, medication classes, and diseases or conditions
which were excluded from the analysis are indicated in
Table 1.
In addition, Beers criteria include medications, such as
indomethacin and diphenhydramine, that are frequently
used as external preparations in Japan. If limited to exter-
nal use, the risk of systemic adverse effect should be low.
Therefore, we decided to exclude external preparations.
Statistical analysis
A multiple logistic regression analysis was performed to
identify predictors of potentially inappropriate medica-
tion use in the patients treated with at least 1 medication.
The dependent variable was inappropriate medication use
independent of disease or condition. Independent varia-
bles were divided into 2 groups. The first group consisted
of patient variables, such as age, gender, abnormal labora-
tory test results in the last 90 days (which were defined as
laboratory values that were abnormal when compared to
standard values), physical restraint for the last 7 days, ADL
disability, cognitive impairment, depression, length of
stay, number of diseases, number of medications used per
day, medication cost per day, and psychotropic drug use
Table 2: Patient characteristics
Characteristics Number of patients as a 
percentage of the total
(N = 1669)
Gender
Male 25.3
Female 74.7
Age
65 – 69 3.7
70 – 74 7.1
75 – 79 13.9
80 – 84 22.2
85 – 89 24.8
90 - 28.4
Mean age (years) 84.5
4 or more diseases 31.4
ADL score of 2 or more* 69.1
CPS score of 2 or more** 76.3
DRS score of 3 or more*** 7.1
Number of medications
1 or more 94.1
6 or more 36.2
9 or more 11.9
Psychotropic drug use 18.6
*ADL: MDS ADL Self-Performance Hierarchy
**CPS: Cognitive Performance Scale
***DRS: Depression Rating ScaleBMC Geriatrics 2006, 6:1 http://www.biomedcentral.com/1471-2318/6/1
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(as defined by the Narcotics and Psychotropics Control
Law in Japan). The second group consisted of facility var-
iables and were facility type, method of reimbursement
for the cost of medication, and the number of beds in the
facility. Medication cost per day was converted to natural
logs because it had a long-tail distribution. All variables
were entered into the multiple logistic regression model
by the backward stepwise method. Data were analyzed by
using SPSS 12.0J software for Windows.
Results
The demographic characteristics of the population stud-
ied are listed in Table 2. Their gender and ages were simi-
lar to data in a national survey of the same period [55].
Of the 1669 patients, 356 (21.1%) were treated with at
least 1 potentially inappropriate medication independent
of the disease or condition in 2003 Beers criteria, and 308
(86.5%) of them treated with 1 medication on the list, 41
(11.5%) with 2, and 7 (2.0%) with 3. Table 3 shows the
prevalence of prescription of each medication or medica-
tion class. The most commonly used inappropriate medi-
cation was ticlopidine, which was used by 107 patients
(6.3%).
There were 300 patients (18.0%) who met the criteria for
potentially inappropriate medication dependent on dis-
ease or condition. 244 (81.3%) of them were treated with
1 medication on the list, 51 (17.0%) with 2, 3 (1.0%)
with 3, and 2 (0.7%) with 4. Table 4 shows the prevalence
of potentially inappropriate medication use dependent
on disease or condition. The highest prevalence of inap-
propriate medication use was for 165 among 548 patients
with chronic constipation, who were prescribed inappro-
priate medications, such as calcium channel blockers,
anticholinergics, and tricyclic antidepressants.
Table 5 shows the results of the multiple logistic regres-
sion analysis to identify predictors of inappropriate med-
ication use, independent of disease or condition.
Psychotropic drug use (OR = 1.511), medication cost per
day (OR = 1.173) and the number of medications used
per day (OR = 1.140) increased the risk of inappropriate
medication use, while age (OR = 0.981) decreased the
risk.
Discussion
Prevalence of potentially inappropriate medication use 
independent of disease or condition
The prevalence of prescription of potentially inappropri-
ate medication based on the 2003 Beers criteria were
13.4% in the United States [46], and 5.8 to 25.7% in 8
European countries [42]. On earlier versions of the crite-
ria, they were 10.5 to 54.7% in patients in nursing homes
[9,14,21,26,27,29,30,33,39] and 2.2 to 35.6% in patients
in the community [10-12,16-18,20-25,28,31,32,34-
37,40-46]. The prevalence in this study was essentially the
same. Parenthetically, there were 5 (0.2%) terminally ill
patients in the sample but inappropriate medication was
not prescribed for this group.
Table 3: Prevalence of inappropriate drug prescription (Independent of disease or condition)
Drugs Severity* Number of patients as a percentage of total
(N = 1669)
Pentazocine High 0.2
Muscle relaxants and antispasmodics High 0.9
Amitriptyline High 0.0
Long-acting benzodiazepines High 1.9
Disopyramide High 0.2
Digoxin >0.125 mg/d Low 0.0
Short-acting dipyridamole Low 0.0
Gastrointestinal antispasmodic drugs High 0.1
Anticholinergics and antihistamines High 1.4
Ferrous sulfate>325 mg/d Low 0.2
Ticlopidine High 6.3
Doxazosin Low 1.5
Thioridazine High 0.1
Short-acting nifedipine High 2.0
Cimetidine Low 1.5
Indomethacin High 0.1
Desiccated thyroid High 0.1
Methyldopa High 0.1
Use of any inappropriate drugs 21.1
* Severity: Defined conceptually as a combination of both the likelihood that an adverse outcome would occur and the clinical significance of that 
outcome should it occur [7].BMC Geriatrics 2006, 6:1 http://www.biomedcentral.com/1471-2318/6/1
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The most commonly inappropriately prescribed medica-
tion was ticlopidine. By contrast, ticlopidine is rarely used
in the United States, because clopidogrel, a safer alterna-
tive to aspirin, is available. However, clopidogrel was not
available in Japan at the time of the study, which may
have led to a higher prevalence of inappropriate use than
would have been the case if it had been available. The fact
that ticlopidine was also commonly prescribed in Italy
[30,42], where clopidogrel was also unavailable, may pro-
vide support for this hypothesis. When ticlopidine was
excluded from the list, the prevalence of potentially inap-
propriate medication use independent of the disease or
condition decreased from 21.1% to 16.4%, thus remain-
ing in the range of previous studies.
Anticholinergics and antihistamines, long-acting benzo-
diazepines, short-acting dipyridamole, and short-acting
nifedipine were other medications on the list that were
frequently used. The prevalence of inappropriate prescrip-
tion of dipyridamole and nifedipine use in this study was
slightly higher than in other studies. Propoxyphene was
commonly used in the United States, but was not pre-
scribed for the subjects of this study because it was una-
vailable in Japan. The prevalence of the antiarrhythmic
agent, amiodarone, added to the 2003 Beers criteria, was
also high in previous studies [42,46], but none of the
patient were treated with it in our study because the
national formulary regulation in Japan restricts its use to
cases in which other medications have proved ineffective.
Factors associated with inappropriate medication use 
independent of the disease or condition
The result of the multiple logistic regression analysis in
this study identified psychotropic drug use, number of
medications per day, medication cost per day, and age as
factors associated with inappropriate medication prescrip-
tion in LTC facilities, which was the same as in other
countries [9,10,15,18,19,21,25-32,35-39,42,43,46].
When ticlopidine was excluded from the analysis, the
results did not change greatly, but age and cost of medica-
tion per-day were excluded.
It should be noted that the other patient variables and the
3 facility variables were not selected in the multiple logis-
tic regression analysis. Since Japanese LTC facilities differ
not only in professional staffing levels and medical need,
but in reimbursement for medication costs, we expected
these characteristics to be reflected in the prescription pat-
Table 5: Multiple logistic regression analysis to identify predictors of inappropriate drug use
Variable Odds ratio 95%CI P value Correlation coefficient*
Psychotropic drug use 1.528 1.133 – 2.059 0.005 0.156
Medication cost per day** 1.172 1.011 – 1.360 0.036 0.213
Number of medications 
per day
1.141 1.075 – 1.211 0.000 0.268
Age 0.981 0.965 – 0.998 0.029 -0.124
* The Pearson's bivariate correlation coefficients.
** Cost of medication per day has been converted to natural logs.
Table 4: Prevalence of inappropriate drug prescription (Dependent on disease or condition)
Disease or condition Drug Severity n/N * %
Heart failure Disopyramide, high sodium content drugs High 4/114 3.5
Seizures or epilepsy Chlorpromazine, thioridazine High 2/57 3.5
Blood clotting disorders or 
receiving anticoagulant therapy
Aspirin, NSAIDs, dipyridamole, ticlopidine High 4/27 14.8
Stress incontinence** α-Blockers, anticholinergics, tricyclic antidepressants, long-acting benzodiazepines High 89/1028 8.7
Arrhythmias Tricyclic antidepressants High 1/106 0.9
Insomnia Decongestants, theophylline, methylphenidate, MAOI, amphetamines High 4/92 4.3
Parkinson's disease Metoclopramide, conventional antipsychotics High 19/88 11.4
Cognitive impairment Barbiturates, anticholinergics, antispasmodics, muscle relaxants, CNS stimulants High 52/1273 4.1
Depression Sympatholytic agents High 8/119 6.7
Syncope or falls Short to intermediate-acting benzodiazepine, tricyclic antidepressants High 23/103 22.3
COPD Long-acting benzodiazepines, β-blockers High 1/44 2.3
Chronic constipation Calcium channel blockers, anticholinergics, tricyclic antidepressants Low 165/548 30.1
Use of any of above for each disease or condition 300/1669 18.0
* N: Number of patients with the disease or condition. n: Number of patients treated with any of drug(s) that are inappropriate for that disease or 
condition.
** We could not identify the patients with 'stress incontinence' because the MDS data were limited to 'incontinence' in general.BMC Geriatrics 2006, 6:1 http://www.biomedcentral.com/1471-2318/6/1
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tern. The fact that these variables were not included indi-
cates that the prescription pattern in Japanese LTC
facilities depends on other factors, such as the prescribing
habits of individual physicians.
Limitations
The first limitation of this study is that the sample facili-
ties in this study may have been of higher quality, both in
the standard of care and prescribing habits, which would
lead to a lower prevalence of inappropriate medication
prescription. Second, many have noted that the Beers cri-
teria do not include drug-drug interactions or underpre-
scribing [10,11,27,29,30,35,40,46]. Third, there may be
racial differences in some drugs metabolizing enzymes
[56,57] that affect the incidence of adverse effects as well
as the dosage limitations on the list. Finally, there may be
potentially inappropriate medications for elderly that are
available in Japan but not in the United States, and if there
are, modifications of the Beers criteria based on expert
opinion would be needed for application to Japan. How-
ever, the Japan Geriatrics Society had just published
guidelines for appropriate medication prescription for the
elderly when this paper was submitted [58]. They are a
modification of the 2003 Beers criteria, and the majority
of the guidelines appear to follow the original criteria with
some changes in dose and the addition of several medica-
tions. Thus, although we used the original Beers criteria to
make our study comparable to international studies, our
results appear to be generally applicable to the Japanese
situation.
Conclusion
By focusing on LTC facilities that used the MDS compre-
hensive assessment form, we were able to confirm for the
first time that the prevalence of inappropriate medication
prescription in Japanese LTC facilities was 21% according
to the criteria independent of disease or condition and
18% according to the criteria dependent on disease or
condition, based on the 2003 Beers criteria. The results of
a multiple logistic regression analysis indicated that psy-
chotropic drug use and the number of medications pre-
scribed per day are risk factors of potentially
inappropriate medication use independent of disease or
condition. These results are similar to those of previous
studies in other countries.
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